Patients in Central and Eastern Europe (CEE) have, for many years, faced an uneven playing field in access to medicines.
While some countries in this region have made progress in improving the investment in health and modernising their healthcare systems, differences in access to innovative treatments and consequently in health outcomes and life expectancy continues to persist and requires sustained attention. Closing this gap is not only a healthcare priority, but an economic and social necessity.
In a study commissioned by EFPIA, academic experts from the CEE region highlight this dual reality of progress alongside remaining gaps for healthcare systems.
Read the full report here.
